Form 8-K - Current report:
SEC Accession No. 0001104659-24-037301
Filing Date
2024-03-21
Accepted
2024-03-21 16:17:08
Documents
13
Period of Report
2024-03-21
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249483d1_8k.htm   iXBRL 8-K 22861
  Complete submission text file 0001104659-24-037301.txt   193333

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20240321.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20240321_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20240321_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm249483d1_8k_htm.xml XML 3492
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 24771588
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)